We are live on ! Find out more
ADCT icon

ADC Therapeutics
ADCT

66 hedge funds and large institutions have $177M invested in ADC Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

14% more funds holding

Funds holding: 58 → 66 (+8)

2.79% more ownership

Funds ownership: 44.88% → 47.68% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

35% less capital invested

Capital invested by funds: $273M → $177M (-$96.2M)

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

69% less call options, than puts

Call options by funds: $75K | Put options by funds: $241K

Holders
66
Holders Change
+8
Holders Change %
+13.79%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
9
Reduced
21
Closed
12
Calls
$75K
Puts
$241K
Net Calls
-$166K
Net Calls Change
-$247K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$17.3M
2
BOCH
Blue Owl Capital Holdings
New York
+$5.31M
3
Millennium Management
Millennium Management
New York
+$2.62M
4
PM
Prosight Management
Texas
+$1.79M
5
ECM
ExodusPoint Capital Management
New York
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.58M
2
GGH
GCM Grosvenor Holdings
Illinois
-$4.07M
3
ERSOT
Employees Retirement System of Texas
Texas
-$1.85M
4
Walleye Capital
Walleye Capital
New York
-$1.39M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$684K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$43K +$64.8K +8,942 New
Bank of America
52
Bank of America
North Carolina
$33K +$3.76K +519 +8%
Osaic Holdings
53
Osaic Holdings
Arizona
$25K -$1.64K -226 -4%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$9K +$3.62K +500 +34%
CG
55
Cutler Group
California
$6K +$10.1K +1,400 New
Group One Trading
56
Group One Trading
Illinois
$4K +$6.52K +900 New
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$3.5K +$5.26K +726 New
QT
58
Quantbot Technologies
New York
$2K -$30.8K -4,252 -88%
FWM
59
Focused Wealth Management
New York
$1K – – –
US Bancorp
60
US Bancorp
Minnesota
$1K – – –
Wells Fargo
61
Wells Fargo
California
$1K – – –
Balyasny Asset Management
62
Balyasny Asset Management
Illinois
– -$684K -86,100 Closed
Allianz Asset Management
63
Allianz Asset Management
Germany
– -$491K -61,760 Closed
ECM
64
Endurant Capital Management
California
– -$469K -58,967 Closed
Zurich Cantonal Bank
65
Zurich Cantonal Bank
Switzerland
– -$170K -21,408 Closed
Lazard Asset Management
66
Lazard Asset Management
New York
– -$127K -16,098 Closed
State Street
67
State Street
Massachusetts
– -$112K -14,028 Closed
GCM
68
Graham Capital Management
Connecticut
– -$103K -12,992 Closed
Squarepoint
69
Squarepoint
New York
– -$88K -11,014 Closed
SIAP
70
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– -$9K -1,100 Closed
BCV
71
Banque Cantonale Vaudoise
Switzerland
– -$8K -1,000 Closed
AssetMark Inc
72
AssetMark Inc
California
– -$3K -365 Closed
VVP
73
Venture Visionary Partners
Ohio
– -$795 -100 Closed
Citigroup
74
Citigroup
New York
– -$14 -2 -6%
1 2
3

ADCT Hedge Fund Activity: Q3 2022 in Review

66 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ADC Therapeutics (ADCT) for Q3 2022, worth a combined $177M — down 35% from $273M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ADCT positions and 12 closed out — a net gain of 8 holders — while 9 added to existing stakes and 21 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $17.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $5.58M.

  • 66 institutional investors held ADC Therapeutics (ADCT) as of Q3 2022, up from 58 in Q2 2022.
  • Funds reported $177M of ADC Therapeutics stock for Q3 2022, down 35% quarter-over-quarter.
  • 20 funds opened new ADC Therapeutics positions in Q3 2022 and 12 closed out, a net change of +8 holders.
  • The largest ADC Therapeutics buyer in Q3 2022 was Deerfield Management, an estimated $17.3M added.
  • The largest ADC Therapeutics seller in Q3 2022 was T. Rowe Price Associates, an estimated $5.58M sold.

Based on aggregated 13F filings for Q3 2022.